Researchers developed a micro-volume assay that quantifies T-cell responses and antibodies from fingertip blood, offering a ...

T cell activation—the process by which these key immune defenders recognize threats and mobilize against them—depends on ...

For decades, cancer immunotherapy has focused primarily on CD8+ cytotoxic T lymphocytes as the main executors of tumor cell ...

CoRegen, Inc., a biopharmaceutical company pursuing novel treatments for patients impacted by some of the most aggressive forms of canc ...

A new form of CAR T kills leukemia, multiple myeloma, and sarcoma in mice, opening the door to a future off-the-shelf cancer treatment without chemotherapy.

The current path to CAR-T cell therapy is, by any measure, a logistical ordeal. A patient’s immune cells must be drawn out of the body, shipped to a specialized facility, genetically reprogrammed, ...

A new strategy strengthens the bond between the T cell and a target tumor cell, improving the cytotoxic function of the T cell.

This new type of immunotherapy shows promise for treating different cancers including prostate cancer, leukaemia and lung ...

Researchers at the University of Michigan have revealed that cells use a previously unknown feat of molecular craftsmanship ...